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https://doi.org/10.1016/j.stemcr.2018.11.019SUMMARYTuberous sclerosis complex (TSC) is a rare neurodevelopmental disorder resulting from autosomal dominant mutations in the TSC1 or
TSC2 genes, leading to a hyperactivated mammalian target of rapamycin (mTOR) pathway, and gray and white matter defects in the
brain. To study the involvement of neuron-glia interactions in TSC phenotypes, we generated TSC patient induced pluripotent stem
cell (iPSC)-derived cortical neuronal and oligodendrocyte (OL) cultures. TSC neuron mono-cultures showed increased network activity,
as measured by calcium transients and action potential firing, and increased dendritic branching. However, in co-cultures with OLs,
neuronal defects becamemore apparent, showing cellular hypertrophy and increased axonal density. In addition, TSCneuron-OL co-cul-
tures showed increased OL cell proliferation and decreased OL maturation. Pharmacological intervention with the mTOR regulator ra-
pamycin suppressed these defects. Our patient iPSC-based model, therefore, shows a complex cellular TSC phenotype arising from
the interaction of neuronal and glial cells and provides a platform for TSC disease modeling and drug development.INTRODUCTION
Tuberous sclerosis complex (TSC) is a rare genetic, neurode-
velopmental disorder, which affects multiple organs
(Leung and Robson, 2007), causing benign tumors in the
brain, eyes, heart, lung, liver, kidney, and skin. The neuro-
pathological features in the brain involve cortical tubers
and subependymal nodules (Curatolo et al., 2002). Many
studies also indicate glial-associated phenotypes, including
giant astrocytoma (Beaumont et al., 2015) and white mat-
ter abnormalities (Curatolo et al., 2002; Marti-Bonmati
et al., 2000). TSC is caused by autosomal dominant muta-
tions in the genes TSC1 and TSC2, resulting in a mamma-
lian target of rapamycin (mTOR) pathway hyperactivity
(Curatolo and Moavero, 2012). The mTOR pathway plays
key roles in multiple cellular processes, such as cell growth
(Huang andManning, 2008), and is differentially regulated
by factors, such as rapamycin (Rapa) (Curatolo et al., 2016),
insulin-like growth factor 1 (IGF-1) (Min et al., 2012), and
guanabenz (Guana) (Jiang et al., 2016) depending on cell
type and maturation state, as shown in cellular systems
and in vivo models (Oh and Jacinto, 2011; Watanabe
et al., 2011). Clinical studies showed encouraging improve-
ments in TSC patients after Rapa treatment (Sadowski et al.,
2016). However, to develop improved treatment regimens,
we lack a detailed understanding of how TSC diseasemech-
anisms affect human neuronal and glial cell types.Stem
This is an open access article under the CTSC has been studied in different rodent model systems,
which showed neuronal defects, such as distorted synaptic
balance, neuronal hyperactivity (Bateup et al., 2013), and
axonal defects (Choi et al., 2008), as well as glial defects,
such as reduced myelin (Meikle et al., 2007), increased
oligodendrocyte (OL) progenitor proliferation, and
increased OL death (Carson et al., 2015; Ercan et al.,
2017; Jiang et al., 2016). In human pluripotent stem cell-
based assays, homozygous mutations for TSC2 in human
embryonic stem cell line showed a hyperactive mTOR
pathway, increased soma size, neuronal hyperactivity,
and increased dendritic branching (Costa et al., 2016),
while a heterozygous gene disruption of TSC2 presented
with mild neuronal phenotypic defects (Costa et al.,
2016). Two TSC patient induced pluripotent stem cell
(iPSC)-based studies have been presented before, where
one showed increased astrocyte proliferation, and
increased soma size and decreased neurite length in iPSC-
derived neuronal cultures (Li et al., 2017) and the other
showed delayed neuronal differentiation related to phos-
phatidylinositol 3-kinase/AKT (Zucco et al., 2018). As TSC
neuropathological features implicate both neuronal and
glial cells, and proper neural development involve complex
interactions between different neural cell types, mixed
neuron-glia systems would be valuable to study the modu-
latory actions of mTOR pathway inhibitors on TSC disease
phenotypes.Cell Reports j Vol. 12 j 1–15 j January 8, 2019 j ª 2018 The Author(s). 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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involving neuron-OL co-cultures. While increased
neuronal activity was quantifiable in neuronal mono-cul-
tures, morphological changes, such as increased axonal
density and hypertrophy, only became apparent after the
TSC neurons were co-cultured with humanOLs. Treatment
of known mTOR regulators Rapa, IGF-1, and Guana
confirmed modulating effects in both neurons and OLs
and validated our TSC model for future drug screens to
design treatments for TSC patients.RESULTS
TSC Patient iPSCs Show Normal Stem Cell Properties
and a Decrease in TSC Protein Levels
To generate iPSC-based models for TSC, we selected fibro-
blasts from teenage patients. Patient 1 (P1) carried a hetero-
zygousmutation 2249G >A in theTSC1 gene, resulting in a
de novo mutation W750X reported earlier (Jones et al.,
1999); Patient 2 (P2) had a single nucleotide duplication
(1563dupA in TSC2 gene resulting in frameshift mutation
H522T). Control iPSC lines were generated from one infant
(C1) and two teenagers (C2, C3). Several iPSC clones were
obtained from each patient and control fibroblast line
and verified by sequencing (Figures 1A–1C). To characterize
TSC patient and control iPSCs for pluripotency, we per-
formed standard assays, including immunocytochemistry
for markers OCT3&4, SSEA4, TRA-1-60, and TRA-1-80,
and expression of alkaline phosphatase (Figures S1A–S1F).
To investigate how the patient TSC mutations change
TSC1 and TSC2 protein expression, we performed western
blot analysis (Figures 1D and 1E). The stoichiometric ratio
of TSC1 and TSC2 proteins are known to be tightly regu-
lated in the cell, so changes in the level of one TSC protein
could be expected to lead to changes of the other TSC pro-
tein level. Indeedwhenwe investigated the TSC1 and TSC2
proteins of both patients we found this to be the case. The
level of one TSC patient was obtained by averaging the
levels of different iPSC clones of that patient: four clones
for both P1 and P2 (Figures 1D–1F). By comparing the
average levels of the patients (P1 and P2) to the average
levels of the controls (C1–C3), we found a significant
reduction in both TSC1 (p < 0.03) and TSC2 (p < 0.004)
in TSC iPSCs (Figures 1D and 1E). The TSC protein levels
are controlled for loading and blotting, by measuring the
total protein content on the blot, as described by previous
studies (Gurtler et al., 2013; Rivero-Gutierrez et al., 2014),
although a protein control actin is shown in Figure 1F.
We selected two iPSC clones hVS-233 (P1A) and hVS-248
(P1B) from P1, one iPSC clone hVS-417 (P2C) from P2,
and control iPSC clones hVS-88 (C1), hVS-228 (C2), and
hVS-421 (C3) for the following experiments. Overall, the2 Stem Cell Reports j Vol. 12 j 1–15 j January 8, 2019TSC patient iPSCs showed a significant reduction in both
TSC1 and TSC2 proteins compared with the controls, but
expressed normal stem cell properties, justifying a com-
bined study of both TSC1 and TSC2 patients.
Increased Neuronal Activity in TSC Patient iPSC-
Derived Neuron Mono-cultures
Network hyperexcitability has been reported in several
models of TSC (Bateup et al., 2013; Lasarge and Danzer,
2014; Wang et al., 2007). To investigate neuronal activity
in TSC patients, we generated neuronal cultures from con-
trols C1, C2, andC3, and patient lines P1A, P1B, and P2, ac-
cording to established protocols (Nadadhur et al., 2017). At
day 56, wemeasured spontaneous calcium transients in the
neuronal cultures (standard [Std] conditions; Figures 2A
and 2C). Under Std conditions, the spontaneous calcium
influx frequency in the networks was significantly higher
(p < 0.01, post hoc test) in the TSC neurons (0.12 ±
0.01 Hz; Figures 2C and 2E) compared with the control
neuron cultures (0.065 ± 0.008 Hz; Figures 2A and 2E).
We further studied whether mTOR pathway inhibition,
by administration of Rapa (Std + Rapa) or IGF-1 (Std +
IGF-1), modulated the spontaneous calcium transients
(Figures 2B and 2D). The frequency of calcium transients
in TSC neuron cultures treated with Rapa (Figure 2D) or
IGF-1 (Figures S2G and S2L) reduced to around 0.09 ±
0.006 and 0.089 ± 0.01 Hz, respectively, whereas the fre-
quency in control neurons after Rapa and IGF-1 treatment
remained around 0.069 ± 0.009 and 0.07 ± 0.008, respec-
tively (Figures 2B and S2F). The reduction in the total event
area in the TSC cultures (2.3 ± 0.3) compared with control
cultures (4.2 ± 0.9) under Std conditions showed a trend to-
ward statistical significance (p = 0.08; Figures 2F and S2M).
Lastly, event amplitudes between TSC and control neurons
were similar (Figures 2G and S2N). Overall, the increased
event frequency in the TSC neurons suggests an increase
in neuronal activity, i.e., spontaneous firing, which was
diminished by treatment with Rapa or IGF-1.
To further assess activity, we measured spontaneous ac-
tion potential firing of neuronal cultures from controls
C1, C2, patient lines P1A and P2, differentiated and plated
on multi-electrode arrays (MEAs). At day 106 under Std
conditions, the neuronal firing (measured as spike rate)
was significantly higher in TSC neurons (p < 0.03, unpaired
t test; 1.09 ± 0.14 Hz; Figure 2K) compared with the control
cells (0.53 ± 0.14Hz; Figure 2I), which significantly reduced
to control levels, i.e., 0.52 ± 0.08 Hz upon Rapa treatment
(p < 0.02, unpaired t test; Figures 2L and 2H). ANOVA anal-
ysis between the four groups did not show a statistically
significant difference. Altogether, we found higher sponta-
neous neuronal firing in TSC neuron mono-cultures
suggesting an increased neuronal activity, which was
modulated to control levels after Rapa treatment.
Figure 1. Mutations in TSC Genes Lead to Decreased TSC Protein Levels in Patient iPSCs
(A–C) Sequencing of patient iPSC line (A) P1A, (B) P1B, and (C) P2.
(D and E) Western blot quantifications of (D) TSC1 and (E) TSC2 protein expression in controls and patients iPSC cells. Individual points
indicate the average values of the two patients (P1 and P2) and controls (C1, C2, and C3). P1 and P2 represent four iPSC clones each. A
significant difference was obtained in the mean TSC1 and TSC2 protein expression level between the control and patient groups (p < 0.05,
unpaired one-tailed t test).
(F) Western blots presenting labeled TSC1, TSC2, and actin protein of four iPSC clones of TSC patient P1 and P2, and three control iPSCs
(means ± SEM).
See also Figure S1.
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Dendritic Arborization in TSC Neuron Mono-cultures
To investigate whether TSC patient iPSC-derived neuron
cultures show morphological changes, we measured the
axonal density in the cultures under Std, Std + Rapa, andStd + IGF-1 conditions at day 56 (Figures 3A and S2A). No
significant changes in axonal densities (SMI312-positive
pixels/DAPI-positive cell) were observed in the TSC (Fig-
ure 3D) compared with the control neuron mono-cultures
(Figures 3B–3E). As hypertrophy is a known phenotype ofStem Cell Reports j Vol. 12 j 1–15 j January 8, 2019 3
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soma size (Nissl-positive pixels/DAPI-positive cell). We
did not observe differences in the soma size in the TSC
compared with the control neuron cultures, under Std or
Std + Rapa (Figure 3J), or under Std + IGF-1 conditions (Fig-
ure S2H). To assess differences in dendritic and synaptic
density between TSC patient and control neuron cultures,
we performed staining for dendritic marker MAP2 and pre-
synaptic marker Synaptophysin1 (Figures 3F–3I, S2D, and
S2E). No significant changes in the synaptic (Figure 3M)
and the dendritic densities (Figure 3L) were found between
the TSC and control neuronmono-cultures under Std, Std +
Rapa, or Std + IGF-1 conditions (Figures S2K and S2J). To
study changes in basal dendritic branching, prominent in
TSC (Jaworski and Sheng, 2006), we utilized NeurphologyJ,
an ImageJ plugin, to measure the number of dendritic
branches per neuron (i.e., attachment points per cell; Fig-
ures 3O and S2P), and the ratio between number of
branches per neuron and the dendritic ends (i.e., attach-
ment points/endpoints; Figures 3N and S2O). Interestingly,
the TSC cultures showed a significant increase in the den-
dritic branching, as measured by attachment points per
cell (p < 0.02, ANOVA: p < 0.02; Tukey’s post hoc test),
and attachment points/endpoints (p < 0.0002, ANOVA:
p < 0.0002, Tukey’s post hoc test) compared with control
neuron cultures, which was normalized after Rapa treat-
ment (Figures 3N and 3O). The total number of neurons
in the cultures (Figures 3P and S2Q) remained around 50
to 65 per field of view (FOV) for all groups. Altogether,
although neurite densities did not change and hypertro-
phy was not observant, the TSC neurons do exhibit an
increased basal dendritic branching comparedwith control
neuron mono-cultures.
TSCNeuron-OLCo-cultures ShowHypertrophy and an
Increased Neurite Density
Axonal changes and hypertrophy have been reported in
brain tissue of TSC patients (Ruppe et al., 2014) and TSC
mouse models (Meikle et al., 2007). Considering the white
matter defects in TSC (Ruppe et al., 2014) and the mTOR
pathway involvement in OL development and maturationFigure 2. Increased Network Activity in TSC Neuron Mono-culture
(A–D) Representative traces of calcium influx of neuronal cultures gen
Rapa (B and D) culture conditions. The multicolor traces in (A–D) rep
(E) Average calcium event frequency for the patient (P1 and P2) and c
SEM). Average for P1 was obtained from P1A and P1B. The average calc
analysis of two to four differentiations. Asterisks in (E) indicate stat
(F and G) Calcium event amplitude (F) and event area (G) in control
(H–L) Average spike rate (Hz) at 50 days post plating on MEAs under
independent experiments; means ± SEM). Asterisks in (H) indicate u
activity in control neurons under; (I) Std and (J) Std + Rapa conditio
See also Figure S2.(Meikle et al., 2007;Wahlet al., 2014),weexaminedwhether
neuronal abnormalities increase through complex interac-
tions with OLs. To measure morphological changes in
neuron-glia cultures, we grew co-cultures of neurons and
OLs from TSC and control cells (CN + CO, CN + PO, PN +
CO, andPN+ PO).Wefirst generated neurons andOLs sepa-
rately and later co-cultured neurons (day 37) and OLs (day
65) under Std conditions for another 28 days and included
treatments with Rapa (Std + Rapa) or Guana (Std + Guana)
from day 7 of co-culture on (Figures 4A and S4A). Since
IGF- administration could affect OL generation, we used
Rapa andGuana asmTOR pathwaymodulators. The axonal
density significantly changed between the different co-cul-
tures (p < 0.004, ANOVA; Figures 4A–4D and 4I). The PN +
PO culture showed a statistically significant 4-fold increase
in axonal density comparedwith the CN+CO (p < 0.01, Tu-
key’s post hoc test). CN+POcultures appeared tobe similar to
control co-cultures and statistically different from PN + PO
(p < 0.03, Tukey’s post hoc test) cultures (Figures 4A–4D and
4I). This suggested that the increased axonal density did
not increase just through elevated signaling from TSC OLs.
Consistent with this hypothesis, PN + CO cultures showed
a 3-fold increase in axonal density compared with CN +
CO and CN + PO cultures, although not significant with a
post hoc test. Treatments with Rapa or Guana did not sup-
press the increased axonal density (Figures 4I and S4B).
The total number of cells in the co-cultures under Std and
treated conditions remained the same (Figure S4F). There-
fore, when co-cultures contained both TSC neurons and
TSC OLs, the axonal density significantly increased
compared with cultures containing control neurons, which
was unaffected by treatment with Rapa or Guana.
The soma size also significantly changed between the
different co-cultures (p < 0.007, ANOVA; Figures 4E–4H
and 4J). There was a statistically significant difference
in soma size between PN + PO and CN + CO cultures
(p < 0.02, Tukey’s post hoc test), and between the Std and
the Std + Rapa condition in the PN + CO culture (p < 0.04,
Tukey’s post hoc test; Figure 4J). The decrease between
the Std and the Std + Rapa condition in the CN + PO and
PN + PO cultures was not statistically significant (Figure 4J).s Can Be Modulated by Rapa
erated from control and TSC patients, under Std (A and C) and Std +
resent activity in 12 regions of interest per FOV.
ontrol (C1, C2, and C3) neurons under Std and Std + Rapa (means ±
ium event frequency of every iPSC line is calculated by averaging the
istical differences found in Tukey’s post hoc test, *p < 0.05.
and patient groups under Std and Std + Rapa conditions.
Std and Std + Rapa condition from C1, C2, P1A, and P2 (H) (n = 6–8
npaired t test, *p < 0.05. A representative raster plot showing the
ns and TSC neurons under; (K) Std and (L) Std + Rapa conditions.
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size (Figure S4C). Altogether, when co-cultures contained
both TSC neurons and TSC OLs, the soma size significantly
increased compared with cultures containing control neu-
rons and control OLs. Rapa showed regulating effects on
soma size when co-cultures contained TSC neurons and/or
TSC OLs.
To study how interactions between TSCneurons and TSC
OLs affect the density of neuronal processes after long pe-
riods of time, we transplanted control (CN + CO) and
TSC (PN + PO) neuron-OL populations into the brain of
immunocompromised RAG2nullmice. After transplanting
neuronal populations, we observed an abundant incorpo-
ration of human (HN-positive) cells in the mouse brain at
2.5 months post-transplantation (Figures S5A and S5B).
To identify the human neurons in the mixed neuron-OL
grafts, they were labeled with Synapsin-GFP viral construct
before transplantation of mixed neuron-OL populations.
HN-positive andGFP-positive cells were spread over several
brain regions including the cerebral cortex (Figures S5C–
S5F), the caudate putamen, and the olfactory bulb. While
the total number of grafted control and patient neurons re-
mained the same (Figure S5G), the average neurite length
(GFP pixel density per HN-positive soma) in the PN + PO
grafts (7,349 ± 1,247) was significantly higher (p < 0.02)
compared with the CN + CO grafts (3,504 ± 233; Fig-
ure S5H). Therefore, mixed TSC neuron-OL populations
showed increased neurite densities compared with control
neuron-OL grafts at 2.5 months post-transplantation.
Overall, changes in neurite density and hypertrophy in
TSC patient cells can be measured in mixed neuron-OL
populations both in vitro and in vivo, which can be partially
altered by mTOR regulators.
Altered OL Properties in Mixed TSC Neuron-OL
Populations
As TSC patients show glial dysfunctions, we further inves-
tigated whether TSC neuron-OL co-cultures show OL ab-Figure 3. Increased Basal Dendritic Branching in TSC Patient Neu
(A) Schematic of neuronal differentiation protocol under the Std and
(B–I) Immunochemistry of axonal marker SMI312, nuclear marker DA
Rapa (E), and dendritic marker MAP2 and pre-synaptic marker Synapto
TSC Std + Rapa (I) at day 56 for C1, C2, C3, P1, and P2 (n = 6–8 inde
(J) Soma size is measured as the mean number of Nissl-positive pixe
(K) Total axonal density per soma is calculated as the number of SMI
(L) Total dendritic density per soma is calculated as the number of M
(M) Number of synapses is expressed as the number of Synaptophysin
(N–P) Ratio of dendritic attachment points/endpoints of dendrites (N
total number of neurons per field of view (FOV) measured by number
Scale bars, 25 mm. Asterisks in (N) and (O) indicate statistical significa
*p < 0.05, ***p < 0.0005. While several differences were found using T
also Figure S2.normalities. To study whether TSC neuron-OL co-cultures
affected OL maturation, we analyzed the ratio of MBP/
OLIG2-positive cells in the different co-cultures with and
without Rapa or Guana treatment (Figures 5B–5F and
S4D). While ANOVA analysis did not show significant
changes (Figure 5F), t test analysis showed a significant
decrease in OL maturation in PN + PO (0.04 ± 0.003)
compared with CN + CO (0.13 ± 0.03; p < 0.03, t test) cul-
tures, which improved after treatment with Rapa and
Guana (0.10 ± 0.03 and 0.07 ± 0.004, respectively; Figures
5F and S4D). Overall, TSC neuron-OL co-cultures showed
reduced maturation, which was improved by Rapa and
Guana treatment.
To study whether co-cultures with TSC neurons and/or
OLs affected OL proliferation, we measured the number
of OLs in mono- and co-cultures. In mono-cultures, we
found a significant 2-fold increase in the number of
OLIG2-positive cells in TSC (OLIG2/DAPI cells; p < 0.02,
unpaired t test, Figures S3A–S3C) compared with control.
We further found an increase in the number of the bromo-
deoxyuridine (BrdU)-positive cells 2 hr post addition in the
TSC cultures (Figures S3D–S3F), confirming increased pro-
liferation. However, there were no changes in the number
of BrdU-positive cells 1 week post BrdU labeling (Figures
S3G–S3I), suggestive of cell death in TSC cultures, which
was further confirmed by an increase in the cleaved caspase
3-positive cells in TSC glial cultures (Figures S3J–S3L). In co-
cultures, we also found significant changes in the number
of OLs (OLIG2/DAPI cells) between the different groups
(one-way ANOVA; p < 0.0001). Post hoc analysis showed a
4-fold significant increase (p < 0.0002, Tukey’s post hoc
test) in the number of OLIG2-positive cells in the PN +
PO (0.22 ± 0.05; Figures 5E and 5G) compared with the
CN + CO (0.048 ± 0.01; Figures 5B and 5G) cultures. In
addition, when the TSC OLs were co-cultured with control
neurons (CN + PO; 0.15 ± 0.01; Figures 5C and 5G), a three-
times significant increase (p < 0.01, Tukey’s post hoc test) in
the OLIG2/DAPI-positive cells compared with CN + COronal Mono-cultures
Std + Rapa conditions.
PI in control Std (B), control Std + Rapa (C), TSC Std (D), TSC Std +
physin1 in control Std (F), control Std + Rapa (G), TSC Std (H) and
pendent differentiations; means ± SEM). P1 includes P1A and P1B.
ls per soma.
312-positive pixels per DAPI-positive soma.
AP2-positive pixels per DAPI-positive soma.
1-positive puncta per soma.
), number of dendrites (i.e., attachment points) per soma (O), and
of Nissl- and DAPI-double-positive soma (P).
nt differences found using one-way ANOVA and Tukey’s post hoc test,
ukey’s post hoc, only the most important one’s are represented. See
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showed no significant changes in theOLIG2/DAPI-positive
cells compared with CN + CO cultures (Figure 5G), indi-
cating that TSC patient neurons do not affect proliferation
levels of control OLs. Interestingly, PN + PO cultures under
Std + Rapa conditions were significantly reduced compared
with PN + PO cultures under Std conditions (p < 0.04; Tu-
key’s post hoc test; Figure 5G). Treatment with Guana did
not normalize OL numbers (Figure S4E). Hence, TSC pa-
tient OL cultures show increased proliferation, which
increased in co-culture with control and TSC neurons,
which was modulated by Rapa.
To study proliferation of TSC OLs in vivo, transplanted
control (CN + CO) and TSC (PN + PO) neuron-OL popula-
tions were studied 2.5 months post-transplantation.
HumanOL somas were traced by OLIG2 and HN double la-
beling. The numbers of TSC OLs in the PN + PO grafts
(0.33 ± 0.02) were significantly increased (p < 0.02)
compared with OL numbers in the CN + CO grafts
(0.12 ± 0.03; Figure S5I). So, after in vivo transplantation,
the number of OLs increased in the grafted mixed TSC
neuron-OL populations.
Altogether, TSC patient OLs showed a significantly
increased proliferation when co-cultured with control neu-
rons, which further increased by the addition of TSC pa-
tient neurons both in vitro and in vivo, and could be normal-
ized by Rapa treatment.DISCUSSION
TSC neuropathology is known to involve defects in both
neuronal and glial cell populations; however, the inter-rela-
tionships between each neural cell type during disease pro-
gression is unclear, hampering the development of treat-
ment strategies. Here we present evidence for an
interaction between neurons and OLs leading to changes
in axonal density, cellular hypertrophy, and OL cell prolif-
eration, using TSC patient iPSC-based neuron-OL co-cul-
tures. However, increased basal dendritic branching and
enhanced neuronal activity appeared also in neuron
mono-cultures in the absence of OLs. Administration of
mTOR pathway regulators reduced the increase in networkFigure 4. Hypertrophy and Increased Axonal Density in TSC iPSC-
(A–D) Immunocytochemistry of co-cultures, showing SMI312 and DAP
groups.
(E–H) Nissl soma staining in co-cultures of CN + CO (E), CN + PO (F),
(I and J) Total axonal pixel density (I) and average soma size (J) per ce
(means ± SEM) was obtained in total from n = 4–9 independent expe
Scale bars, 25 mm. Asterisks in (I) and (J) indicate statistically signifi
*p < 0.05, **p < 0.005, only the most important differences are repr
See also Figures S4 and S5.activity and partly normalized the cellular defects. Overall,
we present TSC patient iPSC-derived models involving
TSC1 and TSC2 mutations, showing several known TSC-
associated neuronal and OL phenotypes.
Here, we generated TSC patient-derived iPSCmodels that
mimic some of the known effects of TSC mutations in the
CNS.We substantially expand on previous observations re-
ported by Li et al. (2017), who investigated iPSC-derived
neural stem cell (NSC), neuronal, and astrocyte morpho-
logical properties from a single patient carrying a c.1444-
2A > C mutation in TSC2. The authors showed an increase
in NSC and astrocyte proliferation, hypertrophy, and neu-
rite abnormalities in patient cultures (Li et al., 2017).While
we did find an increase in the number of basal dendrites, we
observed no significant changes in cell soma size in TSC pa-
tient neuron mono-cultures in contrast to Li et al. (2017).
This might underlie differences in the culture set up, such
as the generation of different neuronal subtypes, or the
supplementation of rodent astrocytes (Nadadhur et al.,
2017). In the current study, we didmeasure changes in neu-
rite density and hypertrophy when neurons were co-
cultured with OLs, next to increased OL cell proliferation
and decreased OL maturation, indicating that interactions
between neurons andOLs are of utmost importance for the
development of TSC-associated phenotypes. In our TSC
neuron mono-cultures, we further showed an increase in
spontaneous calcium event frequency, consistent with
the network hyperactivity seen in the TSC mouse model
(Bateup et al., 2013), and an altered inhibition reported
in TSC patient tissue (Talos et al., 2012). The MEA data
showed that an increase in activity is also present at the
level of action potential generation, which is the output
of the summation of calcium activity. Lastly, our patient-
derived iPSC models involved either TSC1 or TSC2 domi-
nant mutations. TSC2 gene loss often causes a more severe
phenotype (Kothare et al., 2014), as also seen in mouse
studies (Onda et al., 1999; Zeng et al., 2011). As specific ge-
netic variations in the TSC genes lead to variable disease
symptoms and severity in patients (Jentarra et al., 2011),
there is a need for model systems that involve either
TSC1 or TSC2 mutations.
Interestingly, while we did not measure a difference in
axonal density in the neuron mono-cultures, the presenceDerived Neuron-OL Co-cultures
I expression in CN + CO (A), CN + PO (B), PN + CO (C), and PN + PO (D)
PN + CO (G), and PN + PO (H) groups.
ll in co-cultures measured at day 28 of co-culturing. Mean per group
riments including C1-, C3-, P1B-, and P2-derived neurons and OLs.
cant differences found in one-way ANOVA and Tukey’s post hoc test,
esented in the graph.
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most important determinant to allow axonal differences.
OLs have critical roles in regulating neuronal survival,
the stability of the axon (Morrison et al., 2013), and
neuronal assembly (Simons and Trajkovic, 2006). Further-
more, it is suggested that myelinated axons need OLs for
metabolic support, i.e., maintenance of ATP homeostasis
(Philips and Rothstein, 2017). To ensure firing of action
potentials and activity of Na+ and K+ channels, neurons
need a significant amount of ATP. This might further
explain why neuron-OL co-cultures (or mixed neural or-
ganoid cultures) can maintain neuronal health for longer
periods of time, while neuron mono-cultures degenerate
at certain stages. So this could also suggest that the neu-
rons in mono-cultures versus the neurons in co-cultures
had different maturation states and that only at more
mature stages do axonal differences in TSC became
apparent. Together, co-culture model systems give the op-
portunity to study morphological defects in TSC neuronal
populations that might be absent in neuronal mono-cul-
tures, and thereby supports the use of mixed neural cul-
tures for future screens.
Administration of mTOR pathway inhibitors to the
neuron-OL co-cultures, showed different modulating ef-
fects. While Rapa treatment normalized the enhanced
OL numbers and increase in soma size, the axonal density
remained unchanged. Earlier reports showed that the
mTOR pathway is differentially regulated in different neu-
ral cell types (Edinger et al., 2003; Li et al., 2014; Oh and
Jacinto, 2011; Watanabe et al., 2011), and that dose-
dependent Rapa treatment suppresses mTOR hyperactiva-
tion and rescues TSC neuronal phenotypes and epilepsy
in rodent models (Yasuda et al., 2014; Zeng et al., 2008).
Furthermore, Rapa can enhance neurite outgrowth in pri-
mary control neurons (Lyons et al., 1994) and TSC plays a
role in neuronal polarization (Choi et al., 2008). Rodent
models also showed that the mTOR pathway regulates
OL proliferation and maturation (Wahl et al., 2014), as
well as glial abnormalities (Carson et al., 2012). Therefore,
our neuron-OL models confirm that both neuronal and
OL cell types are affected by TSC mutations and that
the mTOR pathway regulators have differential effects
on these cell types.Figure 5. Differential Proliferation and Maturation of TSC OLs in
(A) Schematic of neuron-OL co-culture protocol in the Std and Std +
(B–E) Immunocytochemical images of co-cultures showing OL precurs
CN + CO (B), CN + PO (C), PN + CO (D), and PN + PO (E) groups.
(F and G) Ratio of MBP/OLIG2- (F) and OLIG2/DAPI-positive cells (G
obtained in total from n = 4–9 independent experiments including C
Scale bars, 25 mm. Asterisks in (G) indicate statistically significant di
several differences were found using Tukey’s post hoc only important
***p < 0.001, ****p < 0.0001. See also Figures S3–S5.An increased amount of OLIG2-positive cells was pre-
sent in the TSC cultures, which was highest when TSC
OLs were co-cultured with TSC neurons. This is in line
with earlier studies showing axonal influence on OL pre-
cursor proliferation, maturation, and myelination (Barres
and Raff, 1999; Simons and Trajkovic, 2006), such as
neuron-induced secretion of neurotransmitters and neu-
rotrophins (Leferink and Heine, 2017). Interestingly, a
recent study showed that TSC expression in neurons reg-
ulates OL differentiation via neuronal connective tissue
growth factor (Ercan et al., 2017). The increased OL prolif-
eration in patient neuron-OL cultures was suppressed by
Rapa treatment. While these results support Rapa treat-
ment to normalize OL defects in patients, the treatment
regimen need further study, as earlier reports showed
that both increased and decreased mTOR pathway activa-
tion negatively affects OL maturation (Lebrun-Julien
et al., 2014; Wahl et al., 2014). Similarly, a recent study
showed that TSC1 deletion in OL precursors accelerates
remyelination (McLane et al., 2017), thereby illustrating
the different roles of TSC proteins in OL development
and myelin health. Guana, an antihypertensive drug,
was shown to prevent OL cell death and to induce partial
rescue of myelination defects by altering mTOR-related
endoplasmic reticulum stress via inhibiting Gadd34-PP1
phosphatase (Jiang et al., 2016). However, we did not
find significant changes after Guana treatment. As TSC
phenotypes are also measurable in neuron-OL grafts
in vivo, chimeric mouse models could function to test
treatment dose and strategies. Hence, mixed neuron-OL
populations represent TSC phenotypes in OL populations,
thereby providing physiological models to study the ther-
apeutic effects of mTOR regulators.
In summary, we have used a TSC iPSC-based cell models
to show: (1) common neuronal defects caused by both
autosomal dominant TSC1 and TSC2 mutations in a pa-
tient genetic background; (2) complex neuron-OL interac-
tions in TSC phenotypes; and (3) therapeutic effects of
compounds such as mTOR regulator Rapa, IGF-1, and
Guana. This model opens future prospects for the develop-
ment of disease-relevant cell-based assays that capture the
complex brain interactions underlying TSC and other
mTOR-mediated neuropathies.Co-cultures
Rapa conditions.
or marker OLIG2- and OL maturity marker MBP-positive cells in the
) in the co-cultures at day 28. Mean per group (means ± SEM) was
1-, C3-, P1B-, and P2-derived neurons and OLs.
fferences found in one-way ANOVA and Tukey’s post hoc test. While
differences are represented in the graph, *p < 0.05, **p < 0.005,
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iPSCs and Neuronal Cultures
TSC patient (P1, GM06149; P2, GM03958) and control fibroblasts
(C3, GM23973) were obtained from the Coriell Biorepository (all
teenage donors), and controls C1 (infant) and C2 (teenage) were
obtained from anonymous control donors. The selected TSC pa-
tients were reported with mental retardation and seizures along
with other TSC-related abnormalities. iPSC reprogramming was
done based on polycistronic construct with OCT3/4, c-MYC,
SOX2, and KLF4 (Warlich et al., 2011). All the iPSC lines were
cultured in Essential 8 medium (Gibco) on Geltrex LDEV-free
(Gibco). Generation of in-direct contact iPSC-neuronal mono-cul-
tures was performed as described earlier (Nadadhur et al., 2017)
with slight modifications. Neuronal mono-cultures with a density
of 62.5 K/2.0 cm2 in the Std condition medium contained Neuro-
basal composition with brain-derived neurotrophic factor (BDNF)
(20 ng/mL; Peprotech) and cAMP (1 mM; Sigma). The Std + IGF-1
and Std + Rapa conditions contained Std medium with IGF-1
(10 ng/mL; Peprotech) or Rapa (30 nM; Sigma), respectively. For
detailed culturing methods and culture conditions for MEA exper-
iments please see Supplemental Experimental Procedures.
Glial Cells and Co-cultures
OLs were obtained as described previously (Izrael et al., 2007).
Before neuron-OL co-cultures were generated, we first separately
created neuron mono-cultures (62.5 K/2.0 cm2 density) until day
37 (Nadadhur et al., 2017) and OL progenitors until day 65. To
generate neuron-OL co-cultures, the neuronal coverslips were
removed from rat astrocyte feeder plates and OL progenitors
were passaged with Accutase (Millipore) and plated at a density
of 200 K/2.0 cm2 on neuronal coverslips. The co-cultures were
maintained in Std co-culturemedium (DMEM/F12 andNeurobasal
[1:1; both Gibco], 1% N1 supplement [in-house], 2% B27 supple-
ment [Gibco], 1% NEAA [Gibco], 60 ng/mL T3 [Sigma],
100 ng/mL Biotin [Sigma] medium with NT3 [10 ng/mL; Pepro-
tech], mouse laminin [1 mg/mL; Sigma], BDNF [20 ng/mL], and
cAMP [1 mM]). Fromday 1 to 7 of co-culture, all cells were refreshed
with Std medium. From day 8 to 28 of co-culture, cells were re-
freshed with either Std, Std + Guana (5 mM; Sigma) or Std + Rapa
(10 nM)medium twice a week. At day 28 of co-culture, the cell cul-
ture coverslips were processed for immunocytochemistry.
Calcium Imaging
At day 56, neuronal mono-culture coverslips were incubated with
Fluo-5-AM ester 1 mM in Neurobasal medium without growth fac-
tors for 5 min at 37C and imaged under constant perfusion at
0.5 mL/min rate with Tyrode’s solution (119 NaCl. 2.5 KCl, 2
CaCl2, 2 MgCl2, 25 HEPES, 30 glucose; all in mM) in an Axiovert
200M inverted microscope (Zeiss) using a 403 oil objective (nu-
merical aperture 1.3; Zeiss), a Polychrome IV light source (TILL
Photonics), a 488/6 nm excitation filter (Semrock), a 525/50-nm
emission filter (Semrock), and a 500-nm beam splitter (Semrock).
Images (1 image/s) were acquired using a Cascade 512 EM-CCD
camera (Roper Scientific) and Metamorph 6.2 software (Molecular
Devices). The total length of 4.5 min was recorded per FOV, and a
minimumof five FOVs per coverslipwas recorded each from two to12 Stem Cell Reports j Vol. 12 j 1–15 j January 8, 2019four differentiations for three controls and three TSC lines. For
analysis, image series were stacked using z stack projection in
ImageJ, and regions of interest were placed on a minimum of 12
neurites per FOV. Calcium traces were detected using ‘‘event
detection analysis (EVA)’’ with previously described methods in
MATLAB (Hjorth et al., 2016).
MEA
60MEA200/30iR-Tigr MEAs were used. Spontaneous activity was
recorded, for a period of 10 min, every 10 days at 37C using MC
Rack at a sample rate of 25,000 Hz. Electrode data were filtered on-
line with a 200 Hz high pass and a 5,000 Hz low pass filter (both
second-order Butterworth). Data were stored as .mcd files, which
contain the filtered continuous traces for each electrode together
with the spikes detected using the online threshold detection built
into MC Rack. After selecting electrodes for analysis, chosen data
were converted to asci files for offline analysis using the MC Data
tool. Offline analysis was achieved with custom scripts written in
MATLAB. Spikes were detected from filtered data using an auto-
matic threshold-based method set at 5.53s, where s is an esti-
mate of the noise of each electrode. Spike timestamps were
analyzed to provide statistics on the general excitability of cultures.
The average spike rate (Hz) represents the median of the average
spike rate for all electrodes (AvgSpkRateE1-n). The average spike
rate for each electrode (AvgSpkRateE) was calculated as
AvgSpkRateE = number of spikes/tmax, where tmax is the total length
of the recording in seconds. This is used to control for particularly
high or low firing rates.
Immunofluorescence
For immunocytochemistry, neuronal mono-cultures and neuron-
OL co-culture coverslips were fixed with 4% PFA for 20 min and
processed for staining. For immunohistochemistry, slides were
washed with PBS (6 times for 5 min each in PBS 13), optionally
treated for 2 min with citrate buffer (0.01 M [pH 6]) for antigen
retrieval, followed by washing in PBS (5 min for 1 time). All the
coverslips/slides were blocked for 1 hr at room temperature (RT)
in blocking buffer (5% NGS, 0.1% BSA, 0.3% Triton X-100 in
PBS 13), incubatedwith primary antibody in blocking buffer over-
night at 4C. Next day, after washing again with PBS (6 times for
5 min each), the coverslips/slides were incubated with secondary
antibody solution for 2 hr, washed again (63 for 5 min), and
then mounted with Fluoromount G (Southern Biotech) on glass
slides (VWR; Super frost plus)/glass coverslips. Images were ac-
quired from stained slides using either a Carl Zeiss 510 Meta
confocal microscope with 403 (1.2 numerical aperture) oil objec-
tive or a Leica DM6000B fluorescent microscope with 103, 203,
and 403 magnification. For details of primary antibodies used
please see Supplemental Experimental Procedures.
Cell Property Analysis
Cell properties such as axonal density, dendritic density, soma size,
and the number of synapses; OLIG2- and MBP-positive cells were
measured using Columbus 2.5 online software. Precisely, images
acquired with confocal and fluorescent microscope were analyzed
with algorithms for morphology, soma recognition, and co-locali-
zation tools using pixel density measurement and the number of
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morphological parameters, pixel densities were measured in
each FOV (6–10 per condition/coverslip) with images of 203 or
403 magnification. To quantify dendritic branching, the
NeurophologyJ tool was used in ImageJ.
Western Blot Analysis
Cell lysates were collected from feeder-free iPSCs at day 3 or 4 after
passage and from neuroepithelial stem cells between P1 and P5.
SDS-PAGE was run on Bolt 4%–12% Bis-Tris Plus Gels (Thermo
Fisher Scientific). The PVDF membranes were blocked with 5%
non-fat dry milk in TBS-0.05% Tween, followed by primary anti-
body incubations at 1:1,000 concentration in 5% BSA in TBS-
0.05% Tween and incubated ON at 4C (primary antibodies are
listed in Supplement Information). The blots were then washed
thrice for 10 min with TBS-Tween and incubated with secondary
antibody in milk-TBS-Tween for 1 hr at RT. After washing thrice
again, bands were visualized using SuperSignal West Femto sub-
strate (Thermo Scientific) on Odyssey Fc imaging system (LI-
COR). Primary antibodies against TSC1 (no. 6935) and TSC2
(no. 4308; both from Cell Signaling Technology) were used at
1:1,000 concentrations. The secondary antibody used was horse-
radish peroxidase rabbit antibody (1:1,000; no. 7074S, Cell
Signaling Technology).
Statistical Analysis
All statistical analysiswas performedusing Prism7 software. All the
raw data were tested for normal distribution and then analyzed us-
ing unpaired t test or one-way ANOVA, depending on group
numbers. In cases where significant differences were obtained in
the ANOVA (p < 0.05), a Tukey’s post hoc test was performed.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and five figures and can be found with this article on-
line at https://doi.org/10.1016/j.stemcr.2018.11.019.
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